BEAT — Heartbeam Income Statement
0.000.00%
Last trade - 00:00- $61.04m
- $58.67m
Annual income statement for Heartbeam, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 0.788 | 2.29 | 13 | 15.3 | 19.9 |
| Operating Profit | -0.788 | -2.29 | -13 | -15.3 | -19.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.07 | -4.43 | -13 | -14.6 | -19.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.07 | -4.43 | -13 | -14.6 | -19.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.07 | -4.43 | -13 | -14.6 | -19.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.07 | -4.43 | -13 | -14.6 | -19.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.141 | -0.567 | -1.59 | -0.72 | -0.73 |
| Dividends per Share |